↓ Skip to main content

Antipsychotic medication for early episode schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, June 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs
1 blog
twitter
15 tweeters

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
95 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antipsychotic medication for early episode schizophrenia
Published in
Cochrane database of systematic reviews, June 2011
DOI 10.1002/14651858.cd006374.pub2
Pubmed ID
Authors

John R Bola, Dennis Kao, Haluk Soydan, Clive E Adams

Abstract

Long-term treatment with antipsychotic medications in early episode schizophrenia spectrum disorders is common, but both short and long-term effects on the illness are unclear. There have been numerous suggestions that people with early episodes of schizophrenia appear to respond differently than those with multiple prior episodes. The number of episodes may moderate response to drug treatment.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
South Africa 1 1%
Unknown 93 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 19%
Student > Bachelor 11 12%
Student > Ph. D. Student 11 12%
Researcher 10 11%
Other 8 8%
Other 21 22%
Unknown 16 17%
Readers by discipline Count As %
Medicine and Dentistry 29 31%
Psychology 15 16%
Nursing and Health Professions 10 11%
Social Sciences 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Other 10 11%
Unknown 17 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2020.
All research outputs
#1,387,726
of 15,381,351 outputs
Outputs from Cochrane database of systematic reviews
#3,733
of 11,170 outputs
Outputs of similar age
#16,478
of 219,485 outputs
Outputs of similar age from Cochrane database of systematic reviews
#169
of 524 outputs
Altmetric has tracked 15,381,351 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,170 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.0. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 219,485 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 524 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.